Overview
Connections
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials

How Worldwide Clinical Trials hires

Truth index
B 75/100
Ghost roles
0%
Stale roles
100%
Reposted roles
0%

Worldwide Clinical Trials scores B on the Alion truth index (A is best, E worst), measured over 3 open roles re-checked against its own hiring board: 0% look like ghost listings, 100% have gone stale and 0% are the same role posted again. It measures how much of what this employer publishes turns into a real, finite search - not the employer as a workplace. How the index is computed

Overview

Worldwide Clinical Trials is a top-rated, full-service global CRO. We provide 30+ years of clinical expertise to benefit your study. Learn more about us here.

News

Blog 2 months ago
AI in FSP: Where it Adds Value & How it Stays
By Jay Leonard, Vice President, Enterprise Technology Transformation and Architecture, Worldwide Clinical Trials Dashboards demo well. Everyone likes a clean set of trend lines they can click into, and I can build one in about 20 minutes. But when a spons
Read more
Report
Blog 4 months ago
Tech-Enabled FSP Delivery: What's Changed & Why It Matters for Trial Readiness
Highlights from our XTalks fireside chat with Craig McIlloney, Stephen Rayda, and Jay Leonard. Watch the full conversation on demand. Functional service provider models have supported clinical trials for years. What has changed is that technology now play
Read more
Report
Blog 4 months ago
Strategic Site Selection Accelerates Enrollment in Migraine Safety Study
How therapeutic expertise and site relationships helped deliver critical data ahead of schedule Background A sponsor developing a novel migraine therapy needed supplemental pharmacokinetic (PK) and safety data to support an ongoing late-stage clinical dev
Read more
Report
Blog 4 months ago
Adapting Without Hesitation: How Worldwide Clinical Trials Delivered a Large-Scale Phase III Analgesic Study Under Pressure
Background Worldwide Clinical Trials recently executed a pivotal Phase III, multicenter, randomized,VK1.1 double-blind, placebo-controlled clinical trial evaluating a novel investigational compound for the treatment of acute low back pain associated with
Read more
Report
Blog 4 months ago
Beyond the Data: Translating Five Insights from ASCO 2026 into Strategic Trial Development & Execution
The American Society of Clinical Oncology (ASCO) annual meeting sets the scientific direction for oncology drug development each year. From a landmark RAS-targeted therapy in pancreatic cancer to renewed momentum in immuno-oncology, next-generation antibo
Read more
Report
Blog 4 months ago
AI, Open Source, & the Future of Biostatistics
Jake Gallagher, Worldwide Flex Reflections on innovation and change in statistical programming Artificial intelligence, the rise of open-source tools, and the steady evolution of data standards are changing how statistical programming and biostatistics ge
Read more
Report
Blog 4 months ago
ADA 2026 Takeaways: Where Metabolic Trial Design is Heading
The Worldwide Clinical Trials metabolic team recently connected with sites, sponsors, and colleagues at the American Diabetes Association's (ADA) 2026 Scientific Sessions. Throughout our conversations, a few themes kept surfacing: how the work itself is c
Read more
Report
Blog 4 months ago
Stepping In, Moving Forward: How Worldwide Clinical Trials Rescued & Delivered a Phase II Neuropathic Pain Study
Background When a sponsor changes clinical operations partners mid-study, the margin for error is exceptionally narrow. Timelines are compressed, institutional knowledge must transfer rapidly, and the incoming organization must absorb an established study
Read more
Report
Blog 5 months ago
Why Biomarker Strategy is Becoming the Foundation of Neurodegenerative Drug Development
Neurodegenerative drug development is entering a new era-one increasingly defined by precision. As breakthroughs in disease biology continue to reshape our understanding of disorders like Alzheimer's disease, Parkinson's disease, ALS, and frontotemporal d
Read more
Report
Blog 6 months ago
Five Endpoints Reshaping How Obesity Trials Are Designed
GLP-1 receptor agonists have substantially raised the bar for what constitutes meaningful weight loss in obesity trials. For sponsors developing in this space, the central question has shifted from simply whether a drug can reduce body weight to what else
Read more
Report
Show more news

Tech stack

Technologies named in job postings at Worldwide Clinical Trials over the last 12 months, by layer, with the share of postings for each.
Technologies in use
3
Postings analysed
1
Stack modernity
43/100
Cloud & platforms
GCP
Developer tools
Mandiant capa
Practices & domains
CAPA
Sign in to see how your skills match this stack Sign In

Growth

Hiring Momentum
39/100
Slowing
Open positions
3
0 opened / 0 closed in 30 days
ATS activity
Every ~5 hours
11/03/2026
Hiring Dynamics 0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Communications
33% ▼
HR
33% ▼
Management
33% ▼
Activity Timeline
Added CAPA to stack Oct 2026
New location: United Kingdom Sep 2026
Added Microsoft Office to stack Sep 2026

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
2
Busiest office
Thiruvananthapuram
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Wilmington United States
HQ
Thiruvananthapuram India
1 open roles 1000-5000 est. staff
hires for HR
seen since Jan 2026 job postings

Jobs

≈ $73k – $124k per year (Estimated) · In office · Full-Time · 5+ years exp · United Kingdom
GCP
Cybersecurity
Mandiant capa
MedTech
CAPA
Apply